Video Experimental Relacionado
Updated: Feb 12, 2026
08:29
Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Published on: October 2, 2014
15.2K
Se están desarrollando terapias dirigidas a TROP2 para tratar tumores gastrointestinales
1U.T. M.D. Anderson Cancer Center Pharmacy Clinical Programs, Houston, TX, USA. jerogers@mdanderson.org.
Molecular diagnosis & therapy
|February 11, 2026
Resumen
Las terapias dirigidas al antígeno de la superficie celular del trofoblasto 2 (TROP2), incluidos los conjugados anticuerpo-fármaco (ADC), son prometedoras en los cánceres gastrointestinales (GI). La investigación en curso explora el TROP2
Área de la Ciencia:
- Oncología Oncología.
- Biología Molecular Biología Molecular
- Desarrollo de Drogas Desarrollo de Drogas.
Sus antecedentes:
- El antígeno de la superficie celular del trofoblasto 2 (TROP2) está sobreexpresado en varios tipos de cáncer.
- Los conjugados anticuerpo-droga (ADC) dirigidos a TROP2 están aprobados para los cánceres de mama y pulmón.
- Los ADC de TROP2 tienen toxicidades únicas y requieren cuidados de apoyo específicos.
Objetivo del estudio:
- Revisar el progreso actual de las terapias dirigidas a TROP2 en las malignidades gastrointestinales (GI).
- Explorar el potencial futuro de los agentes que se dirigen a TROP2 en los cánceres gastrointestinales.
- Para resaltar la importancia de descubrir nuevas terapias dirigidas para las neoplasias gastrointestinales.
Principales métodos:
- Revisión de la literatura de estudios preclínicos y clínicos sobre agentes dirigidos a TROP2 en cánceres gastrointestinales.
- Análisis de datos de fase temprana para terapias dirigidas a TROP2 en cánceres colorrectales y gastroesofágicos.
- Examen de las investigaciones en curso y planificadas para los agentes dirigidos a TROP2 en varias neoplasias gastrointestinales malignas.
Principales resultados:
- Los datos de la fase temprana indican que las terapias dirigidas a TROP2 muestran actividad en los cánceres colorrectales y gastroesofágicos.
- Se están desarrollando múltiples agentes dirigidos a TROP2 para una amplia gama de neoplasias malignas, incluidos los cánceres gastrointestinales.
- Se están investigando estrategias de combinación que involucran agentes dirigidos a TROP2.
Conclusiones:
- Las terapias dirigidas a TROP2 representan una vía prometedora para el tratamiento de malignidades gastrointestinales.
- La investigación adicional y los ensayos clínicos son cruciales para establecer la eficacia y seguridad de los agentes dirigidos a TROP2 en los cánceres gastrointestinales.
- El desarrollo de nuevas terapias dirigidas para los cánceres gastrointestinales, incluidos los agentes dirigidos a TROP2, es de importancia crítica debido a las altas tasas de mortalidad.
Videos de Conceptos Relacionados
01:26Anatomy of the Gastrointestinal System
2.9K
The human digestive system is an intricate and essential network for nutrient absorption and waste elimination. It encompasses the gastrointestinal (GI) tract and several accessory organs.
Here's a detailed walkthrough of this complex system:
Here's a detailed walkthrough of this complex system:
2.9K
01:20Gastrointestinal Motility Disorders
1.3K
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
1.3K
01:20Histology of the Gastrointestinal (GI) Tract
3.6K
The GI tract, from beginning to end, is made up of four continuous tissue layers that adjust their structure according to their specific roles. These layers, from innermost to outermost, are known as the mucosa, submucosa, muscularis, and serosa, which are continuous with the mesentery.
The mucosa is sometimes called a mucous membrane due to its mucus-secreting features. This membrane is composed of epithelium, which directly interacts with ingested substances, and the lamina propria, a layer...
The mucosa is sometimes called a mucous membrane due to its mucus-secreting features. This membrane is composed of epithelium, which directly interacts with ingested substances, and the lamina propria, a layer...
3.6K
01:13Therapeutic Index
6.9K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.9K
01:22Physiology of the Gastrointestinal System I: Ingestion and Propulsion
2.1K
The physiology of the gastrointestinal system begins with ingestion as food enters the mouth.
2.1K
01:22Physiology of the Gastrointestinal System II: Digestion and Absorption
2.0K
The gastrointestinal (GI) tract, extending from the mouth to the anus, plays a pivotal role in the digestion and absorption of nutrients. This process involves both mechanical and chemical actions facilitated by various enzymes.
Digestion begins in the mouth, where food undergoes mechanical breakdown by chewing and combines with saliva. Salivary amylase, an enzyme in saliva, starts the breakdown of starches into maltose. The food then travels down the esophagus to the stomach.
In the stomach, a...
Digestion begins in the mouth, where food undergoes mechanical breakdown by chewing and combines with saliva. Salivary amylase, an enzyme in saliva, starts the breakdown of starches into maltose. The food then travels down the esophagus to the stomach.
In the stomach, a...
2.0K